{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:21:48Z","timestamp":1791876108998,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.esmoop.2021.100235","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T21:35:23Z","timestamp":1628285723000},"page":"100235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Impact of deleterious variants in other genes beyond BRCA1\/2 detected in breast\/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge"],"prefix":"10.1016","volume":"6","author":[{"given":"M.","family":"Bono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Fanale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Incorvaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cancelliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fiorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Cal\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Filorizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.R.","family":"Corsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Brando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Madonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cucinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Scalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Barraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Guadagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Pedone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Badalamenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4370-2008","authenticated-orcid":false,"given":"A.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Bazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.esmoop.2021.100235_bib1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1186\/s12885-020-07250-0","article-title":"Screening of BRCA1\/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC)","volume":"20","author":"El Ansari","year":"2020","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.esmoop.2021.100235_bib2","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3390\/cancers12051158","article-title":"Hereditary breast and ovarian cancer in families from Southern Italy (Sicily)\u2014prevalence and geographic distribution of pathogenic variants in BRCA1\/2 genes","volume":"12","author":"Incorvaia","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.esmoop.2021.100235_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10549-008-9906-7","article-title":"Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?","volume":"113","author":"Russo","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.esmoop.2021.100235_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1200\/EDBK_238977","article-title":"The role of BRCA testing in hereditary pancreatic and prostate cancer families","volume":"39","author":"Pilarski","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"5","key":"10.1016\/j.esmoop.2021.100235_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1158\/1055-9965.EPI-12-0195","article-title":"Risk of pancreatic cancer in breast cancer families from the Breast Cancer Family Registry","volume":"22","author":"Mocci","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.1016\/j.esmoop.2021.100235_bib6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/gim.2014.153","article-title":"BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study","volume":"17","author":"Zhen","year":"2014","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.esmoop.2021.100235_bib7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jmg.2004.028829","article-title":"Cancer risks in BRCA2 families: estimates for sites other than breast and ovary","volume":"42","author":"van Asperen","year":"2005","journal-title":"J\u00a0Med Genet"},{"issue":"4","key":"10.1016\/j.esmoop.2021.100235_bib8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","article-title":"NCCN Guidelines Insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020","volume":"18","author":"Daly","year":"2020","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"9","key":"10.1016\/j.esmoop.2021.100235_bib9","first-page":"3003","article-title":"Beyond BRCA1 and BRCA2: deleterious variants in DNA repair pathway genes in Italian families with breast\/ovarian and pancreatic cancers","volume":"9","author":"Germani","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"9","key":"10.1016\/j.esmoop.2021.100235_bib10","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.3390\/cancers12092415","article-title":"Detection of germline mutations in a cohort of 139 patients with bilateral breast cancer by multi-gene panel testing: impact of pathogenic variants in other genes beyond BRCA1\/2","volume":"12","author":"Fanale","year":"2020","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.esmoop.2021.100235_bib11","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/cncr.29903","article-title":"Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: differences based on germline mutation status","volume":"122","author":"Shah","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.esmoop.2021.100235_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-3-319-70197-4_8","article-title":"Multi-gene panel testing in breast cancer management","volume":"173","author":"Fountzilas","year":"2018","journal-title":"Cancer Treat Res"},{"issue":"4","key":"10.1016\/j.esmoop.2021.100235_bib13","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jmoldx.2019.03.001","article-title":"Multi-gene panel testing of 23,179 individuals for hereditary cancer risk identifies pathogenic variant carriers missed by current genetic testing guidelines","volume":"21","author":"Neben","year":"2019","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.esmoop.2021.100235_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.16.00066","article-title":"Breast and ovarian cancer penetrance estimates derived from germline multiple-gene sequencing results in women","volume":"1","author":"Kurian","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"suppl 2","key":"10.1016\/j.esmoop.2021.100235_bib15","first-page":"147","article-title":"Recent enhancements to the genetic risk prediction model BRCAPRO","volume":"14","author":"Mazzola","year":"2015","journal-title":"Cancer Inform"},{"key":"10.1016\/j.esmoop.2021.100235_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.critrevonc.2019.05.012","article-title":"Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives","volume":"140","author":"Gori","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.esmoop.2021.100235_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920975326","article-title":"BRCA1\/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype\u2013phenotype correlation in a cohort of 531 patients","volume":"12","author":"Incorvaia","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.esmoop.2021.100235_bib18","doi-asserted-by":"crossref","first-page":"682445","DOI":"10.3389\/fonc.2021.682445","article-title":"Prevalence and spectrum of germline BRCA1 and BRCA2 variants of uncertain significance in breast\/ovarian cancer: mysterious signals from the genome","volume":"11","author":"Fanale","year":"2021","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.esmoop.2021.100235_bib19","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/humu.20880","article-title":"Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results","volume":"29","author":"Plon","year":"2008","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.esmoop.2021.100235_bib20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/humu.22981","article-title":"HGVS recommendations for the description of sequence variants: 2016 update","volume":"37","author":"den Dunnen","year":"2016","journal-title":"Hum Mutat"},{"issue":"10","key":"10.1016\/j.esmoop.2021.100235_bib21","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/annonc\/mdz233","article-title":"Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Stjepanovic","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmoop.2021.100235_bib22","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1158\/1055-9965.EPI-13-0745-T","article-title":"The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer","volume":"22","author":"Janatova","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.esmoop.2021.100235_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MPG.0000000000000106","article-title":"A\u00a0novel nonsense mutation in the EpCAM gene in a patient with congenital tufting enteropathy","volume":"58","author":"Thoeni","year":"2014","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.esmoop.2021.100235_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cncr.29041","article-title":"Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian","volume":"121","author":"Mersch","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.esmoop.2021.100235_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/15384047.2015.1108494","article-title":"Absence of germline CDKN2A mutation in Sicilian patients with familial malignant melanoma: could it be a population-specific genetic signature?","volume":"17","author":"Di Lorenzo","year":"2015","journal-title":"Cancer Biol Ther"},{"issue":"9","key":"10.1016\/j.esmoop.2021.100235_bib26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc.2016.72","article-title":"Hereditary breast and ovarian cancer: new genes in confined pathways","volume":"16","author":"Nielsen","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"10.1016\/j.esmoop.2021.100235_bib27","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/cncr.31242","article-title":"Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy","volume":"124","author":"Dudley","year":"2018","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.esmoop.2021.100235_bib28","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1200\/JCO.19.02808","article-title":"Risk of prostate cancer associated with familial and hereditary cancer syndromes","volume":"38","author":"Beebe-Dimmer","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.esmoop.2021.100235_bib29","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamaoncol.2015.2690","article-title":"Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment","volume":"1","author":"Desmond","year":"2015","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2021.100235_bib30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1186\/s12885-019-5756-4","article-title":"Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations","volume":"19","author":"Tsaousis","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.esmoop.2021.100235_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.29010","article-title":"Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel","volume":"121","author":"Tung","year":"2015","journal-title":"Cancer"},{"issue":"23","key":"10.1016\/j.esmoop.2021.100235_bib32","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk","volume":"372","author":"Easton","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.esmoop.2021.100235_bib33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4143\/crt.2019.559","article-title":"Detection of germline mutations in breast cancer patients with clinical features of hereditary cancer syndrome using a multi-gene panel test","volume":"52","author":"Shin","year":"2020","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.esmoop.2021.100235_bib34","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/tbj.13762","article-title":"Multigene panel testing results in patients with multiple breast cancer primaries","volume":"26","author":"Corredor","year":"2020","journal-title":"Breast J"},{"issue":"2","key":"10.1016\/j.esmoop.2021.100235_bib35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10549-017-4181-0","article-title":"Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients","volume":"163","author":"Crawford","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"19","key":"10.1016\/j.esmoop.2021.100235_bib36","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","article-title":"Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment","volume":"32","author":"Kurian","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.esmoop.2021.100235_bib37","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/gim.2014.40","article-title":"Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients","volume":"16","author":"LaDuca","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.esmoop.2021.100235_bib38","first-page":"1","article-title":"Multigene hereditary cancer panels reveal high-risk pancreatic cancer susceptibility genes","author":"Hu","year":"2018","journal-title":"JCO Precis Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2021.100235_bib39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/bcr3159","article-title":"Frequency of the CHEK2 1100delC mutation among women with early-onset and bilateral breast cancer","volume":"14","author":"Ding","year":"2012","journal-title":"Breast Cancer Res"},{"issue":"35","key":"10.1016\/j.esmoop.2021.100235_bib40","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1200\/JCO.2012.42.7336","article-title":"CHEK2\u22171100delC heterozygosity in women with breast cancer associated with early death, breast cancer\u2013specific death, and increased risk of a second breast cancer","volume":"30","author":"Weischer","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.esmoop.2021.100235_bib41","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3389\/fonc.2018.00583","article-title":"Contribution of MUTYH variants to male breast cancer risk: results from a multicenter study in Italy","volume":"8","author":"Rizzolo","year":"2018","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.esmoop.2021.100235_bib42","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/ijc.30197","article-title":"Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH","volume":"139","author":"Win","year":"2016","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.esmoop.2021.100235_bib43","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10549-010-0801-7","article-title":"Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer","volume":"124","author":"Wasielewski","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.esmoop.2021.100235_bib44","doi-asserted-by":"crossref","unstructured":"Rennert G, Lejbkowicz F, Cohen I, et\u00a0al. MutYH mutation carriers have increased breast cancer risk. Cancer. 118(8):1989-1993.","DOI":"10.1002\/cncr.26506"},{"issue":"1","key":"10.1016\/j.esmoop.2021.100235_bib45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/diagnostics11010084","article-title":"MUTYH as an emerging predictive biomarker in ovarian cancer","volume":"11","author":"Hutchcraft","year":"2021","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.esmoop.2021.100235_bib46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/gim.2017.85","article-title":"Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history","volume":"20","author":"Chaffee","year":"2017","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.esmoop.2021.100235_bib47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J\u00a0Natl Compr Canc Netw"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702921001964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702921001964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:27:41Z","timestamp":1761856061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702921001964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S2059702921001964"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2021.100235","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of deleterious variants in other genes beyond BRCA1\/2 detected in breast\/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2021.100235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100235"}}